Androgen Receptor Degraders Overcome Common Resistance Mechanisms Developed During Prostate Cancer Treatment

ABSTRACT: RNA-sequencing of VCaP and LNCaP, LNCaP-EnzR, or LNCaP AR-V7 overexpressing prostate cancer cell lines treated with AR degrader ARD-61.

ORGANISM(S): Homo sapiens

PROVIDER: GSE137833 | GEO | 2020/01/12

REPOSITORIES: GEO